Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q6IW
|
|||
| Former ID |
DCL000632
|
|||
| Drug Name |
Rosiglitazone + simvastatin
|
|||
| Drug Type |
Combination drug (small molecular drug)
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 3 | [1] | |
| Company |
GSK
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H11N3O2
|
|||
| Canonical SMILES |
COC1=CC2=C(C=C1)NC(=O)C2=CC3C=NC=N3
|
|||
| InChI |
1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-8H,1H3,(H,16,17)/b11-4-
|
|||
| InChIKey |
KKGJVFQBVRACGR-WCIBSUBMSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of GlaxoSmithKline. | |||
| REF 2 | Clinical pipeline report, company report or official report of GlaxoSmithKline (2009). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.